Headshot of Mark Humphries.

Mark Humphries

Chair in computational neuroscience
University of Nottingham

Mark Humphries is a theorist, neuroscientist and writer.

His lab studies how neurons collectively encode information about the past, present and future to guide behavior. He authored the popular science book “The Spike: An Epic Journey Through the Brain in 2.1 Seconds” and writes extensively about the brain for a broad audience at Medium and elsewhere.

Humphries is chair in computational neuroscience at the University of Nottingham. He previously held a senior fellowship from the United Kingdom’s Medical Research Council at the University of Manchester. Before that, he had a three-year fellowship at Ecole Normale Superieure in Paris. He did his postdoctoral and Ph.D. training at the University of Sheffield.

https://humphries-lab.org/

Get alerts for essays by Mark Humphries in your inbox.

Subscribe to get notified every time a new essay is published.

Explore more from The Transmitter

Grid of human brain scans.

Dose, scan, repeat: Tracking the neurological effects of oral contraceptives

We know little about how the brain responds to oral contraceptives, despite their widespread use. I am committed to changing that: I scanned my brain 75 times over the course of a year and plan to make my data openly available.

By Carina Heller
20 January 2025 | 7 min read
Colorful illustration of a latticework of proteins.

Cracking the code of the extracellular matrix

Despite evidence for a role in plasticity and other crucial functions, many neuroscientists still view these proteins as “brain goop.” The field needs technical advances and a shift in scientific thinking to move beyond this outdated perspective.

By Anna Victoria Molofsky
17 January 2025 | 5 min read
A repeated DNA strand extends farther from the left side of the image with each iteration.

Huntington’s disease gene variants past a certain size poison select cells

The findings—providing “the next step in the whole pathway”—help explain the disease’s late onset and offer hope that it has an extended therapeutic window.

By Angie Voyles Askham
16 January 2025 | 6 min read